Pharmacological activation of SIRT1-AMPK by ginsenoside Rb1: a novel therapeutic strategy for pressure injury via dual suppression of ferroptosis and inflammation.

erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys

RSL3 - Stanford University

http://www.ncbi.nlm.nih.gov/pubmed/41783343

Hang Li; Hongbo Zhu; Hua Zhi; Jinhui Liu; Xuelu Zhao; Yinong Shi; Zhiwen Wang

Mar 5, 2026